These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3220320)
21. [Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status]. Ellinidi VN; Anikeeva NV; Goncharova OA; Krasnozhon DA Vopr Onkol; 2005; 51(2):197-9. PubMed ID: 16223000 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer. Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642 [TBL] [Abstract][Full Text] [Related]
23. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations]. Bolla M; Chedin M; Chambaz E; Gabelle P Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331 [TBL] [Abstract][Full Text] [Related]
24. [Expression of p29, estrogen receptor related protein in primary breast carcinoma. Methodological, anatomoclinical, and DNA content analysis]. Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A Rev Med Chil; 1994 Oct; 122(10):1140-6. PubMed ID: 7659879 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512 [TBL] [Abstract][Full Text] [Related]
26. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer]. Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780 [TBL] [Abstract][Full Text] [Related]
27. Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. Kanitakis J; Zambruno G; Viac J; Tommaselli L; Thivolet J J Cutan Pathol; 1989 Oct; 16(5):272-6. PubMed ID: 2592625 [TBL] [Abstract][Full Text] [Related]
28. Estrogen receptors and the pattern of relapse in breast cancer. Qazi R; Chuang JL; Drobyski W Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445 [TBL] [Abstract][Full Text] [Related]
29. [Estrogen and progresterone receptors in male breast diseases]. Contesso G; Delarue JC; Guerinot F; May-Levin F; Bohuon C Nouv Presse Med; 1977 May; 6(22):1951-3. PubMed ID: 887385 [TBL] [Abstract][Full Text] [Related]
30. Improved measurement of androgen receptors in human breast cancer. Lea OA; Kvinnsland S; Thorsen T Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456 [TBL] [Abstract][Full Text] [Related]
31. Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menses. Axelrod DM; Menendez-Botet CJ; Kinne DW; Osborne MP Cancer Invest; 1988; 6(1):7-14. PubMed ID: 3365573 [TBL] [Abstract][Full Text] [Related]
32. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer. Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889 [TBL] [Abstract][Full Text] [Related]
33. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815 [TBL] [Abstract][Full Text] [Related]
34. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels. Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816 [TBL] [Abstract][Full Text] [Related]
35. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
36. [Hormone receptors and breast cancer prognosis]. Saez S; Pichon MF Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701 [TBL] [Abstract][Full Text] [Related]
37. Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors. Brentani MM; Nagai MA Cancer Detect Prev; 1983; 6(1-2):241-7. PubMed ID: 6883383 [TBL] [Abstract][Full Text] [Related]
38. International comparisons concerning breast cancer and steroid receptors. Matsumoto K; Sakamoto G; Nomura Y Anticancer Res; 1986; 6(4):621-4. PubMed ID: 3752942 [TBL] [Abstract][Full Text] [Related]
39. Clinical factors related to the presence of estrogen receptors in breast cancer: a prognostic stratification analysis. Pascual MR; Lazo R; Fernandez L; Lage A Neoplasma; 1982; 29(4):453-61. PubMed ID: 7133236 [TBL] [Abstract][Full Text] [Related]
40. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer. Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]